https://www.prnewswire.com/news-releases/biosight-launches-a-phase-12-clinical-trial-of-aspacytarabine-in-combination-with-venetoclax-for-first-line-aml-induction-therapy-followed-by-aspacytarabine-consolidation-301685067.html
Biosight Launches a Phase 1/2 Clinical Trial of Aspacytarabine in Combination with Venetoclax for...
/PRNewswire/ -- Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, today...
https://www.biosight-pharma.com/
BioSight - Innovative Cancer Therapeutics
BioSight is a pharmaceutical development company, developing novel cancer-targeted drugs. BioSight's BST-236 is developed for acute myeloid leukemia treatment.
innovativecancertherapeutics
https://archive.org/details/nasa_techdoc_20000011927
BioSIGHT: Interactive Visualization Modules for Science Education : Wong, Wee Lin : Free Download,...
Redefining science education to harness emerging integrated media technologies with innovative pedagogical goals represents a unique challenge. The...
interactive visualizationfor science